Fludarabine for chronic lymphocytic leukemia

N Engl J Med. 2001 Apr 12;344(15):1166-7; author reply 1167-8. doi: 10.1056/NEJM200104123441511.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Chlorambucil / economics*
  • Chlorambucil / therapeutic use
  • Cost-Benefit Analysis
  • Disease-Free Survival
  • Drug Costs
  • Humans
  • Italy
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / economics
  • Value of Life
  • Vidarabine / analogs & derivatives*
  • Vidarabine / economics*
  • Vidarabine / therapeutic use

Substances

  • Antineoplastic Agents
  • Chlorambucil
  • Vidarabine
  • fludarabine